| Identifier |
20190319_nanos_newinfo_1_04-abstract |
| Title |
New Treatments for Multiple Sclerosis |
| Creator |
Sashank Prasad |
| Affiliation |
Harvard Medical School, Brigham and Women's Hospital, Boston, MA |
| Subject |
Multiple Sclerosis; Rituximab; Alemtuzumab; Siponimod; Ocrelizumab |
| Description |
The era of disease modifying therapy for Multiple Sclerosis (MS), which began with ACTH in the 1950s, has truly accelerated in the past 2 decades. Neuro-ophthalmologists should be aware of the important recent therapeutic advances that will impact their patients with MS. |
| Date |
2019-03 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2019: New Information I Should Know |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6mh24b5 |
| Setname |
ehsl_novel_nam |
| ID |
1423178 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6mh24b5 |
